THe Green Organic Dutchman - MMJ (Seite 118)
eröffnet am 14.03.18 16:54:47 von
neuester Beitrag 01.08.23 16:17:31 von
neuester Beitrag 01.08.23 16:17:31 von
Beiträge: 1.325
ID: 1.276.252
ID: 1.276.252
Aufrufe heute: 0
Gesamt: 122.400
Gesamt: 122.400
Aktive User: 0
ISIN: CA12464X1015 · WKN: A3D6NK · Symbol: BZAM
0,0200
CAD
-20,00 %
-0,0050 CAD
Letzter Kurs 06.05.24 CSE
Neuigkeiten
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,2000 | +471,16 | |
| 0,5700 | +55,23 | |
| 5,4500 | +41,56 | |
| 119,40 | +29,92 | |
| 6,5000 | +27,45 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,8744 | -13,43 | |
| 4,1900 | -14,49 | |
| 1,4500 | -20,98 | |
| 11,290 | -42,81 | |
| 0,5001 | -87,59 |
Beitrag zu dieser Diskussion schreiben
Feedback
Sobald die Übernahme von LEAF durch ACB abgeschlossen ist, dürfte sich diese prozentuale Auflistung nochmals ändern.
"ETFMG Alternative Harvest ETF", ticker symbol "MJ", listed in the U.S. This ETF has accumulated 4.8 Mn shares of TGOD in just 5 weeks, making TGOD its largest holding.
Wer bei TGOD auf dem Laufenden bleiben möchte, den kostenlosen Newsletter nutzen:
https://geckoresearch.com/
https://geckoresearch.com/
Der Kurs scheint sich erst einmal zu beruhigen, die Zocker verlassen den Markt und das ist auch gut so. Rechne die kommenden Tage nicht mit größeren Kursschwankungen.
Hatte ich es schon reingestellt.
TGOD - 2 ETFs haben sich mit Gesamt 7 Millionen Aktien beteiligt, ausschließlich Käufe über die Börse
Hatte ich es schon reingestellt.
TGOD - 2 ETFs haben sich mit Gesamt 7 Millionen Aktien beteiligt, ausschließlich Käufe über die Börse
Trading Spotlight
http://www.stockhouse.com/news/press-releases/2018/06/11/the…
"The Green Organic Dutchman Announces Receipt of Health Canada Cultivation License for Valleyfield, Quebec
T.TGOD, T.ACB | 1 hour ago
TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that, effective June 8th, its wholly-owned subsidiary, Medican Organic Inc. has received its Cultivation License from Health Canada for the Company’s breeding facility in Salaberry-de-Valleyfield, Quebec (“Valleyfield”). The commissioning of this facility will allow the Company to create proprietary, organically grown strains of cannabis and cannabis seeds.
Located on a 72-acre property, the breeding building will house the cultivation of cannabis and the production of seeds and new strains. This building marks TGOD’s first facility in Valleyfield, which will be followed by the addition of TGOD’s flagship 820,000 square foot state-of-the-art hybrid grow facility, which, when complete, will bring TGOD’s domestic production to 116,000 kgs of high-quality, premium organic cannabis annually. Construction of TGOD’s hybrid facility commenced in early 2018, and to date, site-clearing and earthworks have been completed. To view progress, please visit: https://tgod.ca/.
The history and cultivation of cannabis as a crop has resulted in significant limitations on the research of the plant and its development as an agricultural crop. With the changing regulatory landscape, there is a dramatic need to improve current agronomic traits in the different cannabis strains available to and in the possession of Licensed Producers.
Breeding has many different applications and there are several reasons why TGOD plans to engage in a genetic breeding process, while focusing on growing new cannabis strains specifically tailored for specific medical and commercial uses. The various applications include:
Improving the traits of existing strains;
Creating new strains by identifying which cannabinoids lead to certain benefits, and then breeding plants that have specific cannabinoid profiles, resulting in potentially patentable products;
Creating strains that, because of their genetic characteristics, are better suited to certain environmental conditions than others;
Increasing the levels of specific cannabinoids. Specific cannabinoids have been proven to have beneficial effects on certain medical conditions, highlighting the need to advance breeding efforts focused on creating strains rich in cannabinoids such as CBD, GBC and THCV. While for many decades breeders have focused on increasing THC levels, the scientific research demonstrating the medicinal properties of CBD has resulted in an increased demand for high CBD strains;
Increasing pest and disease resistance to reduce crop loss;
Aiming to reduce flowering duration, creating direct profitability improvements by increasing the number of harvest per year; and
Stabilizing genetics in order to produce F1 seeds which will enable plant production directly through seeds as are used in crops such as tomato, cucumber and pepper. This will provide an alternate means to cloning for the growing of this crop.
“One of the biggest gaps in the cannabis industry is the stabilization of genetics through modern breeding techniques, a process that is carried out with most agricultural crops. TGOD’s breeding facility will implement marker-assisted selective breeding to improve traits in cannabis, such as disease resistance to reduce the industry need to rely on pesticides. Improving the plant architecture and flower structure will allow for better mechanization of the harvesting process,” said David Bernard-Perron, Vice President, Growing Operations.
“TGOD’s focus on R&D in the area of breeding and plant genetics will further position the Company as a global industry leader. This technology will enable the Company to produce its own high quality organic cannabis seeds and starting material, which TGOD intends to leverage in its international operations. We are very excited to be focusing our efforts on this important area of innovation which will lead to more tailored strain compositions and a more customized premium product for patients and users,” said Robert Anderson, Co-Chairman and CEO.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
Robert Anderson
Chief Executive Officer and Co-Chairman
..."
"The Green Organic Dutchman Announces Receipt of Health Canada Cultivation License for Valleyfield, Quebec
T.TGOD, T.ACB | 1 hour ago
TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that, effective June 8th, its wholly-owned subsidiary, Medican Organic Inc. has received its Cultivation License from Health Canada for the Company’s breeding facility in Salaberry-de-Valleyfield, Quebec (“Valleyfield”). The commissioning of this facility will allow the Company to create proprietary, organically grown strains of cannabis and cannabis seeds.
Located on a 72-acre property, the breeding building will house the cultivation of cannabis and the production of seeds and new strains. This building marks TGOD’s first facility in Valleyfield, which will be followed by the addition of TGOD’s flagship 820,000 square foot state-of-the-art hybrid grow facility, which, when complete, will bring TGOD’s domestic production to 116,000 kgs of high-quality, premium organic cannabis annually. Construction of TGOD’s hybrid facility commenced in early 2018, and to date, site-clearing and earthworks have been completed. To view progress, please visit: https://tgod.ca/.
The history and cultivation of cannabis as a crop has resulted in significant limitations on the research of the plant and its development as an agricultural crop. With the changing regulatory landscape, there is a dramatic need to improve current agronomic traits in the different cannabis strains available to and in the possession of Licensed Producers.
Breeding has many different applications and there are several reasons why TGOD plans to engage in a genetic breeding process, while focusing on growing new cannabis strains specifically tailored for specific medical and commercial uses. The various applications include:
Improving the traits of existing strains;
Creating new strains by identifying which cannabinoids lead to certain benefits, and then breeding plants that have specific cannabinoid profiles, resulting in potentially patentable products;
Creating strains that, because of their genetic characteristics, are better suited to certain environmental conditions than others;
Increasing the levels of specific cannabinoids. Specific cannabinoids have been proven to have beneficial effects on certain medical conditions, highlighting the need to advance breeding efforts focused on creating strains rich in cannabinoids such as CBD, GBC and THCV. While for many decades breeders have focused on increasing THC levels, the scientific research demonstrating the medicinal properties of CBD has resulted in an increased demand for high CBD strains;
Increasing pest and disease resistance to reduce crop loss;
Aiming to reduce flowering duration, creating direct profitability improvements by increasing the number of harvest per year; and
Stabilizing genetics in order to produce F1 seeds which will enable plant production directly through seeds as are used in crops such as tomato, cucumber and pepper. This will provide an alternate means to cloning for the growing of this crop.
“One of the biggest gaps in the cannabis industry is the stabilization of genetics through modern breeding techniques, a process that is carried out with most agricultural crops. TGOD’s breeding facility will implement marker-assisted selective breeding to improve traits in cannabis, such as disease resistance to reduce the industry need to rely on pesticides. Improving the plant architecture and flower structure will allow for better mechanization of the harvesting process,” said David Bernard-Perron, Vice President, Growing Operations.
“TGOD’s focus on R&D in the area of breeding and plant genetics will further position the Company as a global industry leader. This technology will enable the Company to produce its own high quality organic cannabis seeds and starting material, which TGOD intends to leverage in its international operations. We are very excited to be focusing our efforts on this important area of innovation which will lead to more tailored strain compositions and a more customized premium product for patients and users,” said Robert Anderson, Co-Chairman and CEO.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
Robert Anderson
Chief Executive Officer and Co-Chairman
..."
Antwort auf Beitrag Nr.: 57.957.711 von BlackView am 11.06.18 14:00:51Meiner Meinung nach sollte es wieder steigen... schliesslich werden die Umsätz hier gigantisch.
Management and founders halten 24.0% der Aktien
Pre-IPO Shares (2) (5) sind 45.7%
IPO Shares (5) 13.0%
Aurora Shares (3) 17.3%
siehe Seite 23 der Präsentation https://tgod.ca/wp-content/uploads/2018/05/TGOD-May-2018.pdf
Pre-IPO Shares (2) (5) sind 45.7%
IPO Shares (5) 13.0%
Aurora Shares (3) 17.3%
siehe Seite 23 der Präsentation https://tgod.ca/wp-content/uploads/2018/05/TGOD-May-2018.pdf
Antwort auf Beitrag Nr.: 57.944.862 von Jet-Stream am 08.06.18 19:17:31
Ich könnte mir gut vorstellen, dass jetzt der Prozess der Bodenbildung beginnt.
Die Aktie ist aber trotzdem positv stark nachgefragt, siehe Freitag zum Börsenschluß. Die Verluste wurde massiv begrenzt.
Zitat von Jet-Stream: Meine Fresse ... Kennt das Ding keinen Boden?
Ich könnte mir gut vorstellen, dass jetzt der Prozess der Bodenbildung beginnt.
Die Aktie ist aber trotzdem positv stark nachgefragt, siehe Freitag zum Börsenschluß. Die Verluste wurde massiv begrenzt.
alles andere steht in der Präsentation vom Mai 18 https://tgod.ca/wp-content/uploads/2018/05/TGOD-May-2018.pdf
Durchsuchen
